SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark gets USFDA nod for generic asthma drug

15 Jul 2010 Evaluate

Glenmark has received the approval of US health regulator USFDA to introduce generic theophylline tablets, used for treating asthma and other lung diseases. Glenmark Generics Inc (GGI) will start marketing and distributing the medicine, in 400mg and 600 mg strengths, with immediate effect.

 

The market for theophylline tablets is estimated to be USD 8 million per annum and GGI expects a successful launch, based on limited competition existing in this niche segment. Theophylline extended-release tablets are indicated for treatment of symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases such as emphysema and chronic bronchitis. crackcrack

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×